Interpreting the Biopsy Report
If the diagnosis, is Invasive Lobular Carcinoma, what does it mean to say "there appears to be a focal in-situ component"? And since the sample is very small (1 cm long and .1 cm in diameter), how can the pathologist tell that it is either invasive or in-situ, or has features of both? Do the cells look different when they're invasive as opposed to in-situ?
Yeah, I know, it's a technical question, but after all, this diagnosis has a drastic effect on people's lives, and inquiring minds . . . .
Comments
-
Hi Seebee~ Your pathhologists looks at the cells in your specimen to see whether they are invasive or not. Here's is a page that kind of shows what they look for: http://www.breastcancer.org/symptoms/path_report/the_cancer/invasive.jsp
As for yours, they are saying that there is Invasive Lobular Carcinoma and that it appears to have an area in, around or near it of Lobular Carcinoma In Situ. I don't believe this is uncommon. Cancer starts within the cells and then moves to the outside of them, thus the invasive part. They invade the breast, outside the lobular where they began. I hope this makes sense.
-
Seabee--LCIS cells are contained within the lobules and have not broken thru into the surrounding breast tissue.(that's why it's called non-invasive). ILC however has broken thru and gone into the surrounding breast tissue. Pathologists can see this difference on a cellular level from a biopsy sample. It's pretty common to have LCIS found alongside ILC or other types of bc as well. (that's generally how it is found--an incidental finding while they're in there already looking at some other issue.)
Anne
-
The girls are right--it's very common to have LCIS along with ILC. The funny thing about LCIS, though, is that the medical community can't agree on whether it's truly an in situ cancer like DCIS, or if it's just a marker of increased risk for invasive cancer, either ILC or IDC. The majority of oncs take the latter view--that LCIS is not an in situ cancer that then progresses to invasive.
-
Well, those are all good answers, but I'm still not sure how a sample of tissue that small can be recognized as having in-situ features. Of course that's how the mass originated, but once its out it's invasive, so why does it still have in-situ features and what are they?
I'll have a look at that link and see if it helps clarify the matter for me.
As for whether LCIS progresses or not, the only way to find out would be to monitor some. It might be hard to recruit volunteers for that study.
Thanks for the helpful responses.
-
Seabee
My tumor's biopsy was all ILC, but on final pathology after my lumpectomy, there was a small LCIS component indicated on one edge. So I'm thinking that if that portion had been included in the original biopsy, it would've read as yours did.
Remember that all of this stuff is analyzed on the cell level - much cancer and certainly ILC isn't visible to the naked eye. So that "little" 1 cm by .1 cm piece contains a whole lot of cells that have different features that the pathologist uses to identify what they are.
The bad news is that if the diagnosis is Invasive Lobular Carcinoma, it's got to be removed. The good news is that if that LCIS is "part of" the mass that has been identified as LCIS, it'll end up coming out with the tumor, so there won't be that worry about whether it's a pre-cancer or not - it won't matter. My surgeon said the bit of LCIS in mine was just part of the tumor mass and not anything unusual or separate
Good luck to you! As you deal with this diagnosis and make decisions, it can be a little wild. My ILC diagnosis initially freaked me out completely, and then I calmed down and took it one step at a time. I had a lumpectomy and sentinel node biopsy, and now I'm doing radiation. My Oncotype DX test score indicated I'd likely not benefit from chemotherapy, so it wasn't offered.
I hope all goes well.
Coleen
-
Coleen--
Thanks for the good wishes, and of course I wish you and everyone who is plagued by this disease the very best outcome. I'm struck in reading the posts here by how much luck plays a part in the experience one has with BC. I suppose that's true of life in general, but it becomes more obvious when the stakes get higher.
You're right that the pathologist is working strictly on a cellular level, so I'm thinking that the in-situ cells (or the way they group) look somewht different from the invasive ones, just as the cells associated with ductal look different from those associated with lobular, according to one of the answers in the "ask the expert" section of this site. I'd be interested in seeing this difference illustrated somewhere, since it becomes a major basis for the diagnosis. In fact I saw a small illustration somewhere of the differnce in appearance between ductal and lobular, and found it helpful. After seeing that, I think I have a better understanding of how to do self-exams--what to look for and when to be suspicious. "Thickening" doesn't mean much because it's too abstract. "Flattish hard area" would be much clearer as a description.
-
Seabee, pages 1 and 2 of this transcript might be slightly helpful:
http://www.lbbc.org/data/transcript-file/LBBCdcislcis06.pdf
And this might help a bit, too:
http://www.cbcrp.org/RESEARCH/PageGrant.asp?grant_id=1836
Sorry I can't post live links with my browser.
-
Nash--
Thanks very much! Both of these pieces are quite interesting, but the second one seems to me to be getting closer to the truth. If there are differenct subtypes of ductal, why think of lobular as being only one entity, particularly if there are differences in the appearance of the cells, which to me would be a strong indicator of different cell behavior? Assuming that lobular occurs in subtypes completely explains the features that the doctor claims rule out progression. And shouldn't the type that progresses be treated like DCIS?
-
Seabee, I totally agree with you--why do they ignore the subtypes, especially the ones that appear to progress? I'm in a pickle b/c I have both pleomorphic ILC and pleomorphic LCIS. I can't imagine that the LCIS didn't morph into ILC in my case. At first the surgeon, onc and tumor board all said I had to have bilat mast b/c of the pleomorphic subtype. Then I saw another onc who said the subtype didn't matter--in fact, he didn't even differentiate ILC from IDC in terms of treatment. Then tumor board et al decided I was more at risk for mets than a new primary, and thus should just have a lumpectomy. It was enough to make one's head spin.
At any rate, I opted for a lumpectomy b/c I was not at a time/place in my life last year to be able to go through major surgery (bilat mast/reconstruction), but I second guess my decision every day. I figure at the first sign of a local recurrence or new primary, then the girls have got to go. But in the meantime, it's very frustrating to have the docs not all be in agreement on how to handle LCIS, especially pleomorphic LCIS. If they don't really understand it, how are we supposed to make informed decisions?
-
I'm still in the process of getting a final diagnosis, so I haven't had a chance to be confused yet. Some of the same arguments come up in the case of other diseases which are poorly understood--Alzheimer's or Parkinson's, for example. There's debate in both those cases about whether they are one disease or several, whether some of their symptoms are specific to the disease or possibly normal consequences of aging, like arthritic degeneration of the joints. The classification of some unrelated syndromes as "Parkinsonian" further confuses the issue in the latter case. Diagnosis can be a rather arbitrary business.
I opted for a lumpectomy because I know all too well from my mother's experience what a mastectomy entails. I know that in some circumstances it is the only reasonable choice, but I was willing to accept some risk to avoid its short and long-term consequences. If I'm faced with a clear choice between mastectomy and death, then I might reconsider, though today, two days after the "easier" wire-guided lumpectomy, preceded by numerous mammograms, a horrendous core needle biopsy, a CT scan, a bone scan, an MRI, and cardiac clearance, I'm already wondering if it's worth the trouble. :-)
-
I found this discussion interesting because I work in a lab with a pathologist. My initial sympton with my ILC was bleeding from the nipple. Since I had the blood sample, I decided to make a slide and look at it. I could see the small tumor cells in a 3-D configuration. I looked in some of our reference books and found balls of breast cancer cells that looked like what I had. The stomach cancer cells were very similar also. After my mastectomy my path report said extensive LCIS with pagetoid spread and six areas of ILC. Pagetoid spread means that the LCIS was in the ducts and spreading toward the nipple. There's something called a basement membrane at the outside edge of the lobule or duct that is where the duct or lobule stops. If the cancer cells go through that membrane and outside of the lobule or duct they are called invasive. The cells look the same for LCIS and ILC, it just depends on whether they have grown through the basement membrane and out into the other breast tissue or not. ILC cells tend to be smaller and more normal looking than IDC and have to be identified through special stains. My pathologist said that they have to be really careful when looking in the lymph nodes for the ILC because it is easier to miss. The frozen sections that they did during surgery showed my lymph nodes to be clear, but the more careful testing done later showed isolated tumor cells in the first node. I am not a cytotech, so I've had to learn what I was looking at as I went along. All of this information is from my personal experience and understanding and study. If I am wrong about any of this I apologize,but I think this is correct. gandl
-
It's good to hear from someone who has actually worked in a lab. I have no trouble believing that LCIS can become ILC. I would think that given enough time all LCIS would become invasive. The fact that some don't during the time they are observed doesn't mean that they never would. But there are some differnces in the appearance of cells in lobular cancer--i.e. some are more normal-looking than others (pleomorphism), some have the "signet-ring" appearance, etc.,
-
Thanks for that input, gandl. That was very interesting. And a touch disconcerting. I'm sure my PLCIS turned into PILC, also, and some days I think I'm completely insane for not having a bilat mast. But for whatever reason, I just can't bring myself to do it until backed into a corner medically.
I thought it was really interesting that you said the cells you looked at also resembled stomach cancer cells, since women with a mutation of the e-cahedrin gene CDH1 that causes familial gastric cancer are at a higher risk for ILC.
-
I wonder if this might tie in to the fact that lobular is hard to detect because it tends to blend in with normal cells instead of forming a discrete lump, and tends to metastasize to the gastrointestinal tract.
They call lobular "sneaky," which is one way to descriibe it. But maybe it just wants to fit in and be accepted, like Typhoid Mary.
I hope you won't second guess yourself too much, Nash. I;m inclined to think that we should meddle with nature only if absolutely necessary. I don't know why women have to have breasts, and I've never been particularly fond of mine, but I accept the fact that I have them, and that they can't be disposed of easily.
-
Thanks for the kind words, Seabee, and thank for the laugh with the Typhoid Mary line--that was a riot!
-
seabee---personally, I think ILC has to originate from LCIS, but that's just my opinion. My surgeon said LCIS only becomes invasive in a very small number of cases, he quoted me "about 5%". I've seen stats that say 25% to 33% will become invasive over 25 years (as compared to DCIS--25% to 50% will become invasive over 15 years). I think that's why DCIS is treated more aggressively; since it's potential for invasiveness is greater than LCIS.
anne
-
Nash, don't know how others cope with this siituation, but I try to keep my sense of humor. If we're going to give abnormal cells a personality, the next logical step would be to compare them to human individuals.
I finally got my diagnosis and am breathing a bit more easily today, trying not to think about how many hurdles I still have to clear, or how many more times I have to empty my bloody drain.Yuck.
Ann, I think it may be more than an opinion. My mass was multifocal but basically concenrated in one spot, which I'd be willing to bet was originally LCIS.
Categories
- All Categories
- 679 Advocacy and Fund-Raising
- 289 Advocacy
- 68 I've Donated to Breastcancer.org in honor of....
- Test
- 322 Walks, Runs and Fundraising Events for Breastcancer.org
- 5.6K Community Connections
- 282 Middle Age 40-60(ish) Years Old With Breast Cancer
- 53 Australians and New Zealanders Affected by Breast Cancer
- 208 Black Women or Men With Breast Cancer
- 684 Canadians Affected by Breast Cancer
- 1.5K Caring for Someone with Breast cancer
- 455 Caring for Someone with Stage IV or Mets
- 260 High Risk of Recurrence or Second Breast Cancer
- 22 International, Non-English Speakers With Breast Cancer
- 16 Latinas/Hispanics With Breast Cancer
- 189 LGBTQA+ With Breast Cancer
- 152 May Their Memory Live On
- 85 Member Matchup & Virtual Support Meetups
- 375 Members by Location
- 291 Older Than 60 Years Old With Breast Cancer
- 177 Singles With Breast Cancer
- 869 Young With Breast Cancer
- 50.4K Connecting With Others Who Have a Similar Diagnosis
- 204 Breast Cancer with Another Diagnosis or Comorbidity
- 4K DCIS (Ductal Carcinoma In Situ)
- 79 DCIS plus HER2-positive Microinvasion
- 529 Genetic Testing
- 2.2K HER2+ (Positive) Breast Cancer
- 1.5K IBC (Inflammatory Breast Cancer)
- 3.4K IDC (Invasive Ductal Carcinoma)
- 1.5K ILC (Invasive Lobular Carcinoma)
- 999 Just Diagnosed With a Recurrence or Metastasis
- 652 LCIS (Lobular Carcinoma In Situ)
- 193 Less Common Types of Breast Cancer
- 252 Male Breast Cancer
- 86 Mixed Type Breast Cancer
- 3.1K Not Diagnosed With a Recurrence or Metastases but Concerned
- 189 Palliative Therapy/Hospice Care
- 488 Second or Third Breast Cancer
- 1.2K Stage I Breast Cancer
- 313 Stage II Breast Cancer
- 3.8K Stage III Breast Cancer
- 2.5K Triple-Negative Breast Cancer
- 13.1K Day-to-Day Matters
- 132 All things COVID-19 or coronavirus
- 87 BCO Free-Cycle: Give or Trade Items Related to Breast Cancer
- 5.9K Clinical Trials, Research News, Podcasts, and Study Results
- 86 Coping with Holidays, Special Days and Anniversaries
- 828 Employment, Insurance, and Other Financial Issues
- 101 Family and Family Planning Matters
- Family Issues for Those Who Have Breast Cancer
- 26 Furry friends
- 1.8K Humor and Games
- 1.6K Mental Health: Because Cancer Doesn't Just Affect Your Breasts
- 706 Recipe Swap for Healthy Living
- 704 Recommend Your Resources
- 171 Sex & Relationship Matters
- 9 The Political Corner
- 874 Working on Your Fitness
- 4.5K Moving On & Finding Inspiration After Breast Cancer
- 394 Bonded by Breast Cancer
- 3.1K Life After Breast Cancer
- 806 Prayers and Spiritual Support
- 285 Who or What Inspires You?
- 28.7K Not Diagnosed But Concerned
- 1K Benign Breast Conditions
- 2.3K High Risk for Breast Cancer
- 18K Not Diagnosed But Worried
- 7.4K Waiting for Test Results
- 603 Site News and Announcements
- 560 Comments, Suggestions, Feature Requests
- 39 Mod Announcements, Breastcancer.org News, Blog Entries, Podcasts
- 4 Survey, Interview and Participant Requests: Need your Help!
- 61.9K Tests, Treatments & Side Effects
- 586 Alternative Medicine
- 255 Bone Health and Bone Loss
- 11.4K Breast Reconstruction
- 7.9K Chemotherapy - Before, During, and After
- 2.7K Complementary and Holistic Medicine and Treatment
- 775 Diagnosed and Waiting for Test Results
- 7.8K Hormonal Therapy - Before, During, and After
- 50 Immunotherapy - Before, During, and After
- 7.4K Just Diagnosed
- 1.4K Living Without Reconstruction After a Mastectomy
- 5.2K Lymphedema
- 3.6K Managing Side Effects of Breast Cancer and Its Treatment
- 591 Pain
- 3.9K Radiation Therapy - Before, During, and After
- 8.4K Surgery - Before, During, and After
- 109 Welcome to Breastcancer.org
- 98 Acknowledging and honoring our Community
- 11 Info & Resources for New Patients & Members From the Team